Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

Authors

Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S, Roux O, Uschner FE, de Wit K, Zaccherini G, Alessandria C

Publication date

Thu 10/10/2019 - 12:00

Ecrin position

ECRIN supported project

Link

Journal reference

The Lancet Gastroenterology & Hepatology.